glucocorticoid

'This could explain the mixed success of glucocorticoid treatment, which is the only approved approach for treating auditory disorders', says Christopher R.

"The evidence supporting the life-saving benefits of glucocorticoid treatment for premature babies is overwhelming.

However, although glucocorticoids are prescribed for a wide range of conditions, their use is limited by the various side effects including unwanted metabolic effects that can occur during treatment.

Long-term glucocorticoid concentrations as a risk factor for childhood obesity and adverse body-fat distribution.

Using information from Medicare and MarketScan, researchers found that dual therapy with the Janus kinase inhibitor tofacitinib and glucocorticoids was associated with a 96% increase in the risk of herpes zoster, compared with tofacitinib monotherapy (95% confidence interval, 33%-188%).

A large reduction of GR[alpha] in the cytoplasm is a main cause of GR[alpha] deficiency or glucocorticoid resistance.

The consequences of glucocorticoid signaling follow an inverted U-shaped function in which extremely high and extremely low levels can be detrimental.

"Combination therapy with a LABA plus an inhaled glucocorticoid did not result in a significantly higher risk of serious asthma-related events than treatment with an inhaled glucocorticoid alone but resulted in significantly fewer asthma exacerbations," the authors write.

At trial entry, 38% of patients were already receiving triple therapy, and 29% were taking an inhaled glucocorticoid. The authors noted that any patients taking an inhaled glucocorticoid who were randomized to the vilanterol-umeclidinium group would have had to abruptly stop taking their inhaled glucocorticoids.

They found that the mice that were exposed to increased levels of glucocorticoid became twice the weight of those that were exposed to controlled levels of the hormone.

IPA identified GR signaling as the top canonical pathway regulated by glucocorticoid treatment in both control and genistein-exposed mice (Figure 5C).

There are three pharmacologic strategies for the management of post-endodontic pain: 1) Drugs that block inflammatory mediators that activate or sensitize pulpal nociceptors (e.g., NSAIDs and glucocorticoids); 2) Drugs that block impulse propagation along the peripheral nerves; and 3) Drugs that block central mechanisms of hyperalgesia and pain perception.4 Glucocorticoids suppress the inflammatory mediators.

Glucocorticoid is the common name given to the whole family of natural or synthetically produced corrisol-like molecules, which share the property of increasing the blood sugar levels.

Management of glucocorticoid dosing in the growing child with SW-CAH is challenging.

Treatment with single-agent abiraterone results in deficient glucocorticoid synthesis and consequently leads to a compensatory upregulation of hypothalamic-pituitary-adrenal (HPA) with raised levels of adrenocorticotrophic hormone (ACTH) [5].